Indefinite Delivery Contract HHSN272201400045C

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $550,000 single-award contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract and aims to procure tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. Under a $488,000 delivery order, Sloan-Kettering Institute for Cancer Research, a...

The federal agency Joint PEO Chemical and Biological Defense awarded a $10,529,216 Other Transaction Indefinite Delivery Vehicle (IDV) contract to The Methodist Hospital Research Institute (HMRI) to develop and deploy a comprehensive, ultra-high throughput monoclonal antibody discovery and engineering platform named "Antibody Accelerated Engineering by a Universal Selection (ANTAEUS)." This prototype project aims to create an advanced research and technology platform that can rapidly...

The federal government has awarded Biospyder Technologies, Inc., a small business manufacturer, a single-award Indefinite Delivery Contract valued at up to $25,000,000 to provide high-throughput transcriptomics (HTTR) services to the Environmental Protection Agency's (EPA) Office of Research and Development. The contract, set aside for small businesses, supports the EPA's computational toxicology and exposure research by analyzing gene expression changes in animal and plant samples using...

This federal contract IDV award to Biospyder Technologies, Inc., a small business manufacturer, aims to provide the U.S. Environmental Protection Agency's (EPA) Office of Research and Development with targeted RNA sequencing and transcriptomics analysis services. The $25 million indefinite delivery/indefinite quantity (IDIQ) contract, set aside for small businesses, supports the agency's National Center for Computational Toxicology research programs by enabling flexible task orders for molecular...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Emory University to support research efforts from March 2020 through March 2027. Task orders issued against this IDV include delivery of unspecified research services and products related to advancing the understanding and treatment of allergies and infectious diseases. Task order values range from approximately $18,000 to over $11.5 million, with total potential...

The Environmental Protection Agency Office of Research and Development awarded an indefinite delivery contract to Biospyder Technologies, Inc. to provide targeted RNA sequencing analyses. The contract includes a potential value of $9.5 million over five years to evaluate treatment-related changes in gene expression from animal and plant samples. Three firm fixed price delivery orders have been issued against the contract. The first calls for analyses of 97 to 5,000 RNA samples at $123,951 to...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $346.6 million multiple-award Indefinite Delivery Contract (IDC) called the Early Phase Clinical Trial Units (EPCTU) program. This IDC supports Phase 0 through Phase III clinical trials of investigational products against infectious diseases, including small molecules, monoclonal antibodies, vaccines, and other medical countermeasures. The prime...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI) to Duke University's Office of Research Administration Division to support the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA). The $360,000 single-award contract, without any set-aside designation, tasks Duke University as the prime contractor to recover tissue samples and data from various types of cancer to further the goals of the TCGA program. A $248,400 firm...

The U.S. federal government agency has awarded an Other Transaction (OT) Indefinite Delivery Vehicle (IDV) to Vanderbilt University Medical Center (VUMC) to develop an integrated antibody discovery platform capable of identifying antibodies with a high probability of efficacy and developability. The $18,293,274 ceiling value OT IDV is focused on PROTOTYPE ANTIBODY DISCOVERY and is funded by the Joint PEO Chemical and Biological Defense. As a prominent academic medical center and non-profit...